The cyclin-dependent kinase inhibitor p27 KIP1 is a crucial component of the mammalian restriction point, and as such is subject to multiple regulatory mechanisms. It has recently been shown that the abundance of p27 KIP1 is also regulated during apoptosis; p27 KIP1 is cleaved by a Z-VAD-fmk-sensitive caspase during apoptosis induced by growth factor deprivation in endothelial cells, and also following exposure of myeloid leukaemia cells to etoposide. Here, we investigate p27 KIP1 regulation in B-and Tlymphoid cells undergoing apoptosis. We observe that p27 KIP1 is down-regulated following exposure to a variety of apoptotic stimuli including an agonistic anti-Fas antibody, cycloheximide and etoposide. Further investigation revealed the existence of two dierent routes of p27 KIP1 regulation in lymphoid cells undergoing apoptosis. The ®rst pathway is utilized by lymphoid cells stimulated through Fas, is abrogated in a caspase-8-de®cient T-cell line, and is blocked by the caspase inhibitors Z-VADfmk and Boc-D-fmk. In contrast, the loss of p27 KIP1 in cells exposed to cycloheximide and etoposide occurs in the absence of caspase-8 or any Z-VAD-fmk-or Boc-Dfmk-sensitive caspase activities. Thus the down-regulation of p27 KIP1 is a common occurrence in lymphoid cells undergoing apoptosis but, depending on the apoptotic trigger, this can be aected by two dierent mechanisms. Oncogene (2000) 19, 3115 ± 3120.
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KIP2
. These inhibitors have a broad speci®city, negatively aecting the activities of cyclin E-and cyclin A-dependent kinases but acting as positive regulators of cyclin D-dependent kinases (Sherr and Roberts, 1999) . Enforced expression of p27 KIP1 results in G1 arrest and endogenous expression is generally inversely related to proliferative status (Polyak et al., 1994b; Toyoshima and Hunter, 1994) . Accordingly p27 KIP1 levels are low in many types of proliferating cells and expression can be induced by growth-inhibitory treatments including TGFb, rapamycin and serum starvation (Polyak et al., 1994a; Nourse et al., 1994; Kawamata et al., 1998; Luo et al., 1996) .
It is becoming clear that in addition to its role in cell cycle progression p27 KIP1 contributes to the apoptotic response, however, a complex picture is emerging with evidence for both pro-and anti-apoptotic eects. In a study by Hiromura et al. (1999) p27 KIP1 -null mesangial cells and ®broblasts were found to be more susceptible to serum withdrawal-induced apoptosis than their wild type counterparts. Anti-apoptotic eects were also observed when p27 KIP1 was stably overexpressed in human leukaemic cells of myeloid origin in response to a variety of DNA-damaging agents, as well as cycloheximide and an agonistic Fas antibody (Eymin et al., 1999a,b) . In contrast, transient overexpression of p27 KIP1 using adenoviral vectors has been shown to induce apoptosis in transformed epithelial cells and ®broblasts Schreiber et al., 1999; Craig et al., 1997) .
Both p27
KIP1
and its relative p21
CIP1
have been shown to be cleaved by a caspase-3 (CPP32)-like enzyme (possibly caspase-3 itself) in apoptotic endothelial cells, correlating with increased activity of CDK2 (Levkau et al., 1998) . A positive role for activated CDK2 in mediating apoptosis was implied by the ability of dominant-negative CDK2 mutant to suppress apoptosis in these cells (Levkau et al., 1998) . Identi®cation of a putative caspase cleavage site in human p27 KIP1 (DPSD 139 S) was consistent with the production of a 22 kDa, C-terminally truncated version of p27 KIP1 . A subsequent study by Eymin et al. (1999b) (Loubat et al., 1999) . In this study the caspase responsible for cleavage of p27 KIP1 was also sensitive to Z-VAD-fmk and Ac-DEVD-CHO, suggesting a role for caspase-like enzymes in processes other than cell death.
In this study we show that a decrease in the abundance of p27 KIP1 is a common event during the early stages of apoptosis in lymphoid cells of both Tand B-cell origin. However, depending on the apoptotic stimuli, lymphoid cells utilize at least two pathways to down-regulate p27 KIP1 : one is characterized by accompanying PARP cleavage (indicative of caspase-3 activation) and is Z-VAD-fmk-and Boc-Dfmk-sensitive, whereas the second is insensitive to Z-VAD-fmk and Boc-D-fmk and occurs in the absence of caspase-3 and caspase-8.
Down-regulation of p27
KIP1 is an early event during apoptosis mediated by FAS-ligation During our studies of cell cycle regulation in Epstein ± Barr virus (EBV)-immortalized cells we investigated the eect of ligating the Fas receptor on the expression of p27 KIP1 in the EBV-positive B cell line IB4. A rapid apoptotic response was triggered when IB4 cells were treated with an agonistic Fas antibody ( Figure 1a ). Induction of apoptosis was monitored by a PARP cleavage assay which revealed the appearance of a 89 kDa cleavage product with concomitant loss of fulllength PARP within the ®rst hour of exposure. Measurement of p27 KIP1 expression in parallel showed loss of full-length p27 KIP1 in the anti-Fas treated cells, also occurring within the ®rst hour of exposure.
We extended our studies to include lymphoid cells that do not harbour EBV, the B cell line BJAB and the T cell line Jurkat A3. The Jurkat A3 cell line is a subclone of Jurkat that has been selected for its acute sensitivity to Fas-induced apoptosis (Juo et al., 1998) . Similar results were observed in these cells with PARP cleavage being accompanied by loss of full-length p27 KIP1 (Figure 1b, c) , although the extent of both PARP cleavage and p27 KIP1 down-regulation was less pronounced in the BJAB cell line (Figure 1b) . The partial eects of Fas in BJAB cells over this timecourse corresponded to a delayed appearance of morphological signs of apoptosis compared with the other two cell lines (data not shown), suggesting that BJAB cells take longer to implement the apoptotic program following Fas-ligation. Therefore, loss of p27 KIP1 is an early event observed during Fas-induced apoptosis in both B-and T-lymphoid cells and occurs independently of EBV.
Caspase activity is required for Fas-mediated loss of p27 KIP1 Fas-ligation promotes apoptosis by initiating a caspase cascade (Peter and Krammer, 1998; Schulze-Ostho et al., 1998; Juo et al., 1998) . As p27 KIP1 has previously been shown to undergo cleavage by caspase(s) in other cell types we asked whether caspases are involved in the Fas-induced loss of p27 KIP1 in lymphoid cells by treating BJAB cells with agonistic Fas antibody in the presence of Z-VAD-fmk (Figure 2a ). Z-VAD-fmk is composed of a methylated tri-peptide (valine-alanineaspartate), modi®ed to function as an irreversible inhibitor of several caspases. Both PARP cleavage and the loss of full-length p27 KIP1 observed 7 h after the ligation of Fas were inhibited by Z-VAD-fmk. Qualitative dierences in the banding pattern detected by the p27 KIP1 antiserum in Figure 2a compared with those shown in Figure 1 re¯ect batch variation in the commercial antisera. Z-VAD-fmk has been reported to inhibit a range of caspases including caspases 1, 3, 5, 7, 8 and 9, but is not a good inhibitor of caspase 2 (Ekert et al., 1999) suggesting that at least one of these caspases is required for the Fas-induced loss of p27 KIP1 . Caspase-8 (FLICE) has been shown to play an essential role in the initiation of the Fas-induced apoptotic cascade (Juo et al., 1998) . Following receptor cross-linking, caspase-8 is recruited to the intracellular domain of Fas via its interaction with the adaptor protein FADD. This results in oligomerization and autoactivation of caspase-8 and it triggers an apoptotic caspase cascade involving caspase-3 (Peter and Krammer, 1998; Schulze-Ostho et al., 1998) . We questioned whether signal transduction through caspase-8 is or not with 0.5 mg/ml agonistic anti-human Fas mouse monoclonal antibody (TCS Biologicals, Clone CH-11) for a total of 7 h (Morley et al., 1998) . Cell culture was as described (Sinclair et al., 1994) . Cells extracts were prepared from equal numbers of cells and used for Western blotting on 15% (p27 KIP1 ) or 10% (PARP) polyacrylamide gels as previously described (Cannell et al., 1998) . Blots were probed with rabbit polyclonal antisera recognising the C-terminus of p27 KIP1 (Santa Cruz, C19) or PARP: (Roche). Solid arrows indicate full-length p27 KIP1 and PARP, while dotted arrows indicate the PARP cleavage product p27 KIP1 regulation during apoptosis in lymphocytes V Frost and AJ Sinclair required for the down-regulation of p27 KIP1 following ligation of Fas. We used a caspase-8-de®cient derivative of the Jurkat A3 cell line, Jurkat 9.2 (Juo et al., 1998) for this investigation. This cell line does not express caspase-8 and is completely resistant to Fasinduced apoptosis, despite expressing wild type levels of cell surface Fas. In the aforementioned study the mutant phenotype of the Jurkat 9.2 cells could be rescued by complementation with wild type caspase-8, demonstrating the requirement for caspase-8 in the Fas-signal transduction pathway and suggesting that caspase-8 de®ciency is the sole genetic lesion conferring resistance to Fas-induced death in these cells.
Four hours after ligation of Fas, the control Jurkat A3 cells showed morphological signs of advanced apoptosis (data not shown) and PARP cleavage ( Figure 2b ). As expected, full-length p27 KIP1 was lost from these cells (Figure 2b ). In contrast, in the cells lacking caspase-8, stimulation of the Fas receptor was unable to produce morphological changes (data not shown), PARP cleavage or loss of p27 KIP1 (Figure 2b ). This strongly suggests that caspase-8 itself or a caspase-8-initiated pathway is required for the Fasinduced down-regulation of p27 KIP1 in Jurkat cells. As previously mentioned, Z-VAD-fmk-sensitive caspase(s) have been shown to cleave p27 KIP1 in vitro and in vivo resulting in 23 kDa and 15 kDa proteins. Neither of these contain the carboxy terminal end of p27 KIP1 but they are recognized with an antibody speci®c for the amino terminus. Surprisingly we detected a 23 kDa cleaved form of p27 KIP1 in untreated T-and B-lymphoid cells whose size was consistent with the caspase-cleaved form of p27 KIP1 detected by others (Figure 2c) . However, the abundance of this form did not increase with induction of apoptosis. This suggests that the loss of p27 KIP1 in Fas-ligated lymphoid cells may occur by an alternative caspase-dependent mechanism which does not require direct caspase cleavage.
Loss of p27
KIP1 during apoptosis of T-lymphoid cells also occurs after inhibition of protein synthesis and induction of DNA damage
In order to investigate whether down-regulation of p27 KIP1 is a general feature of apoptosis in lymphoid cells we compared three distinct mechanisms of apoptotic induction in a single cell line. In addition to Fas-ligation, we investigated inhibition of protein synthesis by cycloheximide and induction of DNA damage using etoposide. In all cases a reduction of p27 KIP1 was observed in Jurkat A3 cells (Figure 3a ,b). These observations indicate that down-regulation of p27 KIP1 is a general feature of apoptosis in Jurkat Tlymphoid cells.
p27
KIP1 loss in T-lymphoid cells undergoing apoptosis can occur by caspase-dependent and -independent mechanisms Interestingly, the caspase-8-de®cient Jurkat 9.2 cells are also susceptible to loss of p27 KIP1 during cycloheximideand etoposide-induced apoptosis (Figure 3c,d) . This shows that caspase-8 activity is not essential to the KIP1 induced by Fas is caspase-dependent. (a) BJAB cells were treated for 7 h with agonistic Fas antibody in the presence of 50 mM Z-VAD-fmk (Calbiochem) or DMSO. Extracts were prepared and subjected to Western blotting as described in Figure 1. (b,c) Control Jurkat A3 cells and caspase-8-de®cient Jurkat 9.2 cells were treated with or without agonistic Fas antibody for 4 or 7 h. Extracts were prepared and used for Western blotting with antisera recognising either the C-terminus of p27 KIP1 (b; Santa Cruz, C19) or the N-terminus of p27 KIP1 (c; Santa Cruz, N20) as described above. In all parts of the ®gure, solid arrows indicate full-length proteins, while dotted arrows indicate cleavage products induction of apoptosis by these agents in Jurkat cells and also rules out an absolute requirement for caspase-8 in the regulation of p27 KIP1 in T-lymphoid cells undergoing apoptosis. To address the potential requirement for caspases further, we employed the broad spectrum caspase inhibitors: Z-VAD-fmk and Boc-D-fmk. The inhibitory mechanism of Boc-D-fmk is based on a single aspartate residue conjugated to a cell permeable¯uoromethyl ketone group rendering it a general inhibitor of aspartyl proteases (Brown et al., 1999) .
Apoptosis was induced in Jurkat A3 cells, either by Fas-ligation, or exposure to cycloheximide or to etoposide. As expected all three forms of apoptosis were associated with PARP cleavage and downregulation of p27 KIP1 (Figure 4) . However, whereas loss of p27 KIP1 was complete in all cases, the extent of PARP cleavage associated with the dierent forms of apoptosis varied. Notably, whereas induction of apoptosis by Fas-ligation was associated with complete loss of detectable full-length PARP within 4 h, both cycloheximide and etoposide produced only partial PARP cleavage, with readily detectable amounts of full-length protein still remaining after 18 h of treatment.
The dierence in the extent of the down-regulation of p27 KIP1 and PARP in cycloheximide-and etoposide-treated Jurkat A3 cells suggested that DEVDspeci®city caspases may not be wholly responsible for the loss of p27 KIP1 in response to these agents. Indeed, experiments with Z-VAD-fmk and BOC-Dfmk con®rmed this suspicion and demonstrated interesting dierences in the mechanism of p27 KIP1 down-regulation in Jurkat A3 cells activated on one hand through the Fas pathway or activated on the other hand with either cycloheximide or etoposide. As expected, Fas-ligation in the presence of Z-VADfmk or BOC-D-fmk prevented the Fas-induced loss of p27 KIP1 in Jurkat A3 cells (Figure 4a ). In contrast, the down-regulation of p27 KIP1 that occurred in response to both cycloheximide and etoposide was insensitive to either caspase inhibitor (Figure 4b , upper panel). The ecacy of Z-VAD-fmk and BOC-D-fmk as caspase inhibitors in these cells was con®rmed as they both prevented the partial PARP cleavage produced by cycloheximide and etoposide (Figure 4b, lower panel) , and also the eects of Fasligation on both PARP and p27 KIP1 (Figure 4a ). Thus in contrast to our observations in Fas-ligated cells, loss of p27 KIP1 can occur in the absence of either ZVad-fmk-sensitive or BOC-D-fmk-sensitive caspases during some forms of apoptosis. To our knowledge this is the ®rst report of a Z-VAD-fmk-insensitive mechanism of p27 KIP1 regulation in apoptotic cells. Furthermore these ®ndings highlight lineage-speci®c dierences in the regulation of p27 KIP1 during apoptosis, as the down-regulation of p27 KIP1 that occurs in etoposide-treated myeloid leukaemia cells is ). An equal volume of DMSO was added in the place of apoptotic stimuli where appropriate. Extracts were prepared and subjected to Western blotting using polyclonal antisera recognizing the C-terminus of p27 KIP1 (Santa Cruz, C19) as described in Figure 1 p27 KIP1 regulation during apoptosis in lymphocytes V Frost and AJ Sinclair inhibited by Z-VAD-fmk (Eymin et al., 1999b) and is therefore caspase-dependent. Our demonstration of at least two dierent mechanisms of p27 KIP1 regulation in apoptotic lymphoid cells supports the notion that removal of p27 KIP1 protein is relevant to the apoptotic process. The loss of cyclindependent kinase inhibitors (CDKIs) is emerging as a frequent event in cells undergoing apoptosis. For example, the p27 KIP1 -related protein p21 CIP1 is a substrate for caspases and is cleaved in human endothelial, epithelial and hepatoma cells undergoing apoptosis (Levkau et al., 1998; Park et al., 1998; Zhang et al., 1999) . In addition, another negative regulator of the cell cycle, retinoblastoma protein (RB) is targeted by a caspase-3 like protease during TNF-and Fasinduced death; expression of uncleavable RB can attenuate the death response to some, but not all inducers of apoptosis (Tan et al., 1997) . Another protein which controls the cell division cycle, MDM2, is also a substrate for caspase-3 during apoptosis (Erhardt et al., 1997; Chen et al., 1997) . Interestingly, MDM2 is cleaved at the same site in non-apoptotic tumour cells (Pochampally et al., 1998) . Similar to our observations of p27 KIP1 in lymphoid cells, a second pathway controlled the cleavage of MDM2 in nonapoptotic cells, as the cleavage of MDM2 failed to correlate with PARP cleavage, suggesting the involvement of a protease distinct from caspase-3. Conversely, a range of mechanistically unrelated apoptotic inducers have been shown to activate cyclin/CDK complexes in the early stages of apoptosis (Shi et al., 1994; Lahti et al., 1995; Meikrantz et al., 1994; Shimizu et al., 1995) . Thus it is becoming clear that many proteins traditionally regarded as cell cycle regulators may also in¯uence a cell's decision to live or die.
